Immune-Related Adverse Events with PD-1 Versus PD-L1 Inhibitors: A Meta-Analysis of 8730 Patients from Clinical Trials

Guru P Sonpavde

Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA02215, USA
Petros Grivas

Department of Medicine, Division of Medical Oncology, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, 1144 Eastlake Ave, E. LG-465, Seattle, WA98109, USA
Yushun Lin

PharmStats, Missouri City, TX77459, USA
Daniel Hennessy

EMD Serono, Inc, Rockland, MA01821, USA; an affiliate of Merck KGaA, Darmstadt, Germany
Jay D Hunt

EMD Serono, Inc, Rockland, MA01821, USA; an affiliate of Merck KGaA, Darmstadt, Germany